This inventor holds 2 USPTO granted patents. Top assignees: Protherics Inc., Therapeutic Antibodies, Inc.. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2001
Title: John Landon: Innovator in Antibody Therapy
Introduction
John Landon is a notable inventor based in London, GB. He has made significant contributions to the field of antibody therapy, holding 2 patents that focus on innovative methods for treating patients suffering from severe conditions.
Latest Patents
One of his latest patents is titled "Antibody fragments in therapy." This patent describes a method of neutralizing TNFα in a patient benefiting from such neutralizing, which involves administering to the patient an IgG Fab fragment that is reactive towards TNFα. This method is particularly beneficial for patients suffering from septic shock or its symptoms. It is preferred that the Fab fragment is derived from polyclonal IgG. Another patent he holds is for the "Production of antibody fragments from whole blood," which further showcases his expertise in this area.
Career Highlights
Throughout his career, John Landon has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Therapeutic Antibodies, Inc. and Protherics Inc. These experiences have allowed him to develop and refine his innovative approaches to antibody therapy.
Collaborations
(Section skipped due to space constraints.)
Conclusion
John Landon's work in antibody therapy represents a significant advancement in medical treatment options. His innovative patents and career achievements highlight his dedication to improving patient outcomes through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile